Postmortem Methamphetamine Redistribution: Why Sampling Site Changes the Result

Prepared by Okorie Okorocha, J.D., M.S., M.S.

Short answer: A postmortem methamphetamine concentration can change with sampling site and the interval between death and collection. Central, peripheral, vitreous, and tissue results are not interchangeable, and published group ratios are not universal correction factors for an individual case.

What postmortem redistribution means

After circulation stops, drug concentrations can change as compounds move from tissues and organs into nearby blood, between vascular compartments, and through degrading cell membranes. This site- and time-dependent process is called postmortem redistribution.

Mechanism reviews describe several potential contributors: release from the lungs, liver, myocardium, and gastrointestinal tract; changing pH and cell-membrane integrity; autolysis; putrefaction; residual early metabolism; and diffusion between adjacent tissues and blood. Basic, lipophilic drugs with a large apparent volume of distribution are often considered more susceptible, but no single physicochemical rule predicts every drug’s behavior.

Methamphetamine is distributed into tissues during life and has been repeatedly studied for postmortem redistribution. The studies do not establish one fixed multiplier. They show why the exact specimen source matters.

Central and peripheral blood can differ

Barnhart and colleagues reported 20 postmortem cases in which central heart-blood methamphetamine was higher than peripheral femoral blood. In five cases with myocardium testing, heart-tissue concentrations were higher than blood concentrations. The authors recommended peripheral blood for interpretation.

A later 18-case distribution study by McIntyre and colleagues reported an average central-to-peripheral methamphetamine ratio of 1.61, an average vitreous-to-peripheral ratio of 1.63, and an average liver-to-peripheral ratio of 5.68. Those averages describe that case series. They do not permit a reviewer to divide a central result by 1.61 and claim to have reconstructed the concentration at death.

Ratios varied between cases. The source of the central sample, postmortem interval, body position, tissue reservoirs, temperature, collection method, and individual pharmacokinetics may all affect the observed relationship.

Paired antemortem and postmortem results provide a different comparison

McIntyre and colleagues later compared antemortem whole blood with postmortem peripheral blood in three medical-examiner cases. The average postmortem-to-antemortem ratio was approximately 1.51 for methamphetamine. This is useful evidence that peripheral concentrations may also change after death.

The study had only three cases. The antemortem specimens were collected shortly before death, and the postmortem specimens were iliac-artery blood collected hours later. The result should be described as a small paired case series, not a universal 50-percent adjustment.

The proposed tissue source is not always the same

Barnhart’s report discussed diffusion between myocardium and cardiac blood. Moriya and Hashimoto, using human observations and a rabbit experiment, emphasized rapid movement from methamphetamine-rich lung tissue through pulmonary veins into the left cardiac chambers during the early postmortem period. Their work suggested that right- and left-heart blood could behave differently.

This disagreement is scientifically important. A finding of higher cardiac than peripheral blood does not, by itself, identify one tissue source or a single mechanism. The collection record should state the chamber or vessel—not merely “heart blood.”

Even femoral blood is not a perfect time capsule

Peripheral blood is usually preferred because it is farther from major central organs and the gastrointestinal tract. Preferred does not mean unchanged.

Wurita and colleagues examined methamphetamine and amphetamine across 21 matrices from one human cadaver, including blood from nine cardiovascular locations. They reported substantial site variation and proposed that methamphetamine in venous blood, including femoral venous blood, might decrease through diffusion across vessel walls during a relatively long postmortem interval.

Because this was a single case, it cannot define the behavior of every femoral specimen. It does show why “femoral” should not be treated as proof that a result equals the circulating concentration at death.

A concentration alone does not prove cause of death

Quigley and colleagues reported substantial overlap between methamphetamine concentrations in deaths attributed to intoxication and cases in which methamphetamine was incidental or death resulted from another cause. In their series, deaths attributed solely to methamphetamine included concentrations from 102 to 17,662 ng/mL, while incidental findings ranged from 91.5 to 9,105 ng/mL.

The ranges should not be converted into a new cutoff. Their value is the demonstration that concentration categories overlap. Tolerance, route, survival interval, hyperthermia, cardiovascular disease, trauma, co-intoxicants, resuscitation, postmortem redistribution, and specimen source can all change the interpretation.

What should be documented for every methamphetamine result

1. The exact anatomical source of every blood specimen, including side, vessel, or cardiac chamber.
2. Whether blood was drawn from an intact ligated vessel, collected after organ removal, or obtained by blind stick.
3. The death-to-collection interval and refrigeration history.
4. Body position, movement, decomposition, trauma, blood loss, and resuscitation.
5. All available matrices, including vitreous, urine, liver, muscle, brain, lung, myocardium, and gastric contents.
6. Methamphetamine and amphetamine concentrations with units, uncertainty, and reporting limits.
7. Chiral or enantiomer analysis when the source of methamphetamine is disputed.
8. The complete analytical method, validation, calibration, controls, chromatograms, and audit trail.
9. Prescribed medications, illicit-use history, tolerance, abstinence, and medical conditions.
10. Autopsy findings, scene evidence, witness history, and other drugs or alcohol.

Questions to ask about a central-to-peripheral ratio

• Were the two samples collected at the same time?
• Were both sites identified and collected with the same technique?
• Is the “central” sample from a specific chamber, vessel, or pooled cavity fluid?
• Could gastric contents, lungs, liver, or heart tissue contaminate or influence the site?
• Does the cited research involve the same drug, matrix, timing, and collection conditions?
• Is the proposed ratio a mean from a group, and what was the range or prediction uncertainty?

Frequently asked questions

Can heart blood be converted to femoral blood with one ratio?

No. Published ratios vary among cases and collection conditions. A group mean does not reconstruct an unknown individual concentration.

Does a femoral result equal the blood concentration at death?

No. Femoral blood is generally preferred, but postmortem changes, collection technique, delay, contamination, and diffusion may still affect it.

Can methamphetamine concentration alone prove fatal intoxication?

No. Published fatal and nonfatal or incidental concentrations overlap. Cause-of-death interpretation requires the complete history, autopsy, co-intoxicants, specimen source, method, and alternative causes.

Does a high liver-to-blood ratio prove redistribution?

It may support tissue accumulation and redistribution potential, but it does not quantify how much the blood concentration changed in that individual.

Bottom line

Postmortem methamphetamine interpretation is a specimen-specific, time-dependent scientific problem. The best-supported opinion identifies exactly what was tested, explains how the concentration may have changed, compares all available matrices, and avoids using a published average as an individual correction factor.

For the broader sampling framework, see Postmortem Blood Sampling Sites: Interpretation Guide. Attorneys can use the companion checklist at OkorieOkorocha.com.

Selected scientific sources

• Pélissier-Alicot AL, Gaulier JM, Champsaur P, Marquet P. Mechanisms underlying postmortem redistribution of drugs: a review. Journal of Analytical Toxicology. 2003;27:533–544.
• Barnhart FE, Fogacci JR, Reed DW. Methamphetamine—a study of postmortem redistribution. Journal of Analytical Toxicology. 1999;23:69–70.
• Moriya F, Hashimoto Y. Redistribution of methamphetamine in the early postmortem period. Journal of Analytical Toxicology. 2000;24:153–155.
• McIntyre IM, Hamm C, Bader E. Postmortem methamphetamine distribution. Journal of Forensic Research. 2011;2:122. doi:10.4172/2157-7145.1000122.
• McIntyre IM, Nelson CL, Schaber B, Hamm CE. Antemortem and postmortem methamphetamine blood concentrations: three case reports. Journal of Analytical Toxicology. 2013;37:386–389. doi:10.1093/jat/bkt040.
• Quigley K, Shanks K, Behonick G, Terrell A. A guide for the interpretation of postmortem methamphetamine findings: a series of case reports. Journal of Forensic Toxicology & Pharmacology. 2014;3:2. doi:10.4172/2325-9841.1000117.
• Wurita A, Hasegawa K, Minakata K, et al. Postmortem redistribution of methamphetamine and amphetamine in blood specimens from multiple vessels and other matrices. Forensic Toxicology. 2016.

Editorial note: This educational synthesis paraphrases the cited literature and does not reproduce publisher tables, figures, or substantial source text. It is not a case-specific opinion.